Galiano‐Castillo 2013.

Trial name or title	Telehealth System to Improve Quality of Life in Breast Cancer Survivors
Methods	Accrual: 72 Accrual target: 80 breast cancer survivors Multi‐centre/single‐centre: not reported but most likely home‐based (paper or registry does not explicitly say this) Phase of trial: not reported Country where trial is being conducted: Spain Any intended follow‐up details: 8 weeks Stated study design: RCT, efficacy study
Participants	Inclusion criteria: • 18 to 65 years of age • Female • Diagnosis of stage I, II, or IIIA breast cancer • Medical clearance for participation • Without chronic disease or orthopaedic disease that would interfere with ability to participate in a physical activity programme • Access to Internet • Basic ability to use the computer or living with a relative who has this ability • Completion of adjuvant therapy except for hormone therapy • No history of cancer recurrence • Interest in improving lifestyle: fitness/stress level • Signed informed consent Exclusion criteria: • Not reported
Interventions	ARM 1: Intervention details: Behavioral telerehabilitation group: Interventions will be based on providing cardiovascular, mobility, strength, and stretching exercises through telerehabilitation system. ARM 2: Comparator details: information about usual care
Outcomes	Primary outcome: Quality of life (European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire 30) Secondary outcomes: Algometry (pressure pain thresholds measured through an electronic algometer) Pain (visual analogue scale and brief pain inventory) Body composition (weight, body mass index, skeletal muscle mass, and percentage of body fat obtained through bioelectrical impedance analysis) Physical measurements (abdominal McQuade test, handgrip strength and back muscle strength via digital dynamometers, and multiple sit‐to‐stand test used to assess general lower extremity endurance) Cardiorespiratory fitness (International Fitness Scale and 6‐minute walk test) Fatigue via PFS‐Revised Anxiety and depression via HADS Cognitive function (Trail Making Test and Auditory Consonant Trigram) Accelerometry (Actigraph tri‐axial accelerometer)
Starting date	Start date: March 2012 Estimated completion date: July 2014
Contact information	Manuel Arroyo‐Morales Email: marroyo@ugr.es
Notes	Trial registration link: https://clinicaltrials.gov/ct2/show/NCT01801527 Sponsor of the trial: Universidad de Granada and Carlos III Health Institute Intention‐to‐treat analysis: not reported Funding considerations: not funded by Pharma or otherwise